Physician
Thomasville-Archdale Pediatrics, PLLC
Thomasville-Archdale Pediatrics, PLLC was paid $41.91M by Medicaid between Jan 2018 and Dec 2024, across 99 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoTHOMASVILLE-ARCHDALE PEDIATRICS, PLLC
THOMASVILLE, NC 27360
THOMASVILLE, NC 27360
33aNPI1427018894assigned 03/28/2006
33bProvider typePediatrics Physician
28Total paid$41.91M
24GClaims1,846,803
24DCodes billed99
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#3 of 433
Median peer was paid$942K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 133,415 | $4.14M | |
| 2019 | 140,023 | $5.24M | |
| 2020 | 104,437 | $3.93M | |
| 2021 | 225,954 | $5.86M | |
| 2022 | 402,961 | $7.56M | |
| 2023 | 390,915 | $7.23M | |
| 2024incomplete | 449,098 | $7.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 187,872 | 167,811 | $11.75M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 77,628 | 68,700 | $7.14M |
| 99199 | Unlisted special service, procedure or report | 14% | 947,582 | 582,895 | $5.97M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.1% | 27,642 | 24,701 | $2.56M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 24,808 | 22,046 | $2.27M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 24,149 | 21,530 | $2.11M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.3% | 91,430 | 81,455 | $1.79M |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.7% | 50,863 | 45,289 | $1.53M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.5% | 14,629 | 12,850 | $1.45M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.9% | 5,817 | 5,682 | $794K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.6% | 23,462 | 21,092 | $685K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 12,312 | 9,944 | $597K |
87 more codes
| D0145 | Oral evaluation for a patient under three years of age | 1.1% | 13,038 | $466K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.0% | 45,374 | $433K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38,820 | $358K |
| 87276 | <1% | 15,437 | $210K | |
| 87275 | <1% | 15,423 | $209K | |
| D1206 | Topical application of fluoride varnish | <1% | 13,041 | $206K |
| 90474 | <1% | 7,887 | $154K | |
| 99050 | <1% | 5,657 | $144K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,034 | $125K |
| 96127 | <1% | 27,526 | $120K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,468 | $102K |
| 99070 | <1% | 9,349 | $82K | |
| 90651 | <1% | 4,429 | $78K | |
| 54150 | <1% | 228 | $72K | |
| 80061 | Lipid panel | <1% | 2,365 | $38K |
| 96161 | <1% | 9,919 | $35K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,954 | $35K |
| 87070 | <1% | 3,409 | $35K | |
| 90686 | <1% | 24,819 | $32K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,414 | $25K |
| 92551 | <1% | 16,270 | $23K | |
| 99051 | <1% | 869 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 574 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 499 | $18K |
| 99173 | <1% | 23,632 | $16K | |
| 90734 | <1% | 770 | $16K | |
| 0072A | <1% | 310 | $16K | |
| 99401 | <1% | 530 | $15K | |
| 0071A | <1% | 291 | $15K | |
| 0001A | <1% | 285 | $15K | |
| 87807 | <1% | 953 | $13K | |
| 0002A | <1% | 247 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 826 | $10K |
| 90620 | <1% | 377 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 910 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 869 | $9K |
| 83655 | <1% | 504 | $7K | |
| 90619 | <1% | 1,485 | $7K | |
| 81002 | <1% | 2,411 | $7K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 68 | $6K |
| 81025 | <1% | 560 | $4K | |
| 97802 | <1% | 41 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 928 | $2K |
| 94664 | <1% | 208 | $2K | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 55 | $2K |
| 90715 | <1% | 556 | $2K | |
| 82947 | <1% | 357 | $2K | |
| E0570 | Nebulizer, with compressor | <1% | 13 | $2K |
| 99462 | <1% | 56 | $2K | |
| 90656 | <1% | 1,565 | $2K | |
| 90633 | <1% | 3,406 | $1K | |
| 99381 | <1% | 14 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 15 | $1K |
| 0124A | <1% | 18 | $1K | |
| 96380 | <1% | 63 | $1K | |
| 99058 | <1% | 56 | $922.60 | |
| 99460 | <1% | 13 | $655.07 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 215 | $626.66 |
| 91300 | <1% | 984 | $195.00 | |
| 90744 | <1% | 2,982 | $146.78 | |
| 90716 | <1% | 280 | $124.91 | |
| 90698 | <1% | 9,465 | $106.70 | |
| 86580 | <1% | 22 | $86.72 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 15 | $55.70 |
| 94760 | <1% | 4,477 | $44.75 | |
| 36416 | <1% | 16 | $6.16 | |
| 90671 | <1% | 2,885 | $5.81 | |
| 94761 | <1% | 13 | $3.49 | |
| 90680 | <1% | 7,938 | $0.47 | |
| 90670 | <1% | 12,273 | $0.09 | |
| 90700 | <1% | 1,951 | $0.03 | |
| 90710 | <1% | 161 | $0.02 | |
| 91307 | 0% | 955 | $0.00 | |
| 99000 | 0% | 373 | $0.00 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 547 | $0.00 |
| 3008F | 0% | 393 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 455 | $0.00 |
| 90381 | 0% | 13 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 12 | $0.00 |
| 90685 | 0% | 1,192 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 726 | $0.00 |
| 90713 | 0% | 168 | $0.00 | |
| 90707 | 0% | 242 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 540 | $0.00 |
| 90648 | 0% | 82 | $0.00 | |
| 91312 | 0% | 18 | $0.00 | |
| 90380 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, CLINT (MEDICAL PRACTICE ADMINISTRATOR)